Clinical trials
Multiple Sclerosis trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 8 |
| Novartis Pharmaceuticals | 4 |
| Sanofi | 2 |
| Chaitanya Hospital, Pune | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| Immunic AG | 1 |
| SpineX Inc. | 1 |
| The Centre for Advanced Research & Development, India | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 20 |
| Multiple Sclerosis, Relapsing-Remitting | 7 |
| Recurrence | 7 |
| Demyelinating Diseases | 1 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
| Optic Neuritis | 1 |
| Spinal Cord Injuries | 1 |
| Stroke | 1 |
| Urinary Bladder, Neurogenic | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.